Recent reports indicated that the serine threonine kinase AKT is constitutively activated in 70–85% of T-ALL (T-acute lymphoblastic leukemia) patients and 38% of the cases show an up-regulation of ERK [13]. This evidence concerns the gene MARK2 and acute lymphoblastic leukemia.